Company: HVIIR
Filing Date: 2025-12-23
Form Type: S-4
Source: 0001493152-25-029121
Chunk: 135

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-12-23
Form: S-4
Chunk 135
---
 proceeds from the    
 Trust Account would be used to repay the working capital loans. Up to $2,500,000 of such      
 working capital loans may be convertible into private placement units of New ONE Nuclear      
 at a price of $10.00 per Unit at the option of the lender. As of September 30, 2025, no such  
 working capital loans were outstanding;                                                       |

| ● | the                                                                                   
 fact that Nicholas Geeza, HVII’s chief financial officer, is entitled to an aggregate 
 of $10,000 per month for services rendered to HVII;                                   |

| ● | the                                                                                        
 fact that HVII has agreed to pay consulting and advisory fees of $11,000 per month, with   
 a discretionary annual bonus of up to $25,000, to an affiliate of the Sponsor for services 
 related to the execution and consummation of HVII’s initial business combination, which    
 payments commenced in September 2025;                                                      |

| ● | the                                                                                               
 fact that the Sponsor is entitled to $25,000 per month to an affiliate of the Sponsor for         
 office space, utilities and secretarial and administrative support, which amount was an aggregate 
 of $15,000 per month prior to September 1, 2025; and                                              |

| ● | the                                                                                       
 fact that the Sponsor and HVII’s officers and directors will lose their entire investment 
 in HVII if an initial business combination is not completed within the Completion Window. |

These interests may influence HVII’s directors in making their recommendation that you vote in favor of the Business Combination Proposal and the transactions contemplated thereby. These interests were considered by the HVII Board when it approved the Business Combination. Please see the section of this proxy statement/prospectus entitled “ The Business Combination — Interests of HVII’s Directors and Officers in the Business Combination.”

ONE Nuclear does not believe that any of its directors or officers have any actual or potential material conflicts of interest with unaffiliated security holders of HVII with respect to the Business Combination, including whether to proceed with the Business Combination, or the approval of the Condition Precedent Proposals.

| 84 |

HVII may engage one or more of its IPO underwriters or one of their respective affiliates to provide additional services to HVII, which may include acting as M&A advisor in connection with an initial business combination or as placement agent in connection with a related financing transaction. HVII’s IPO underwriters are entitled to receive Deferred Underwriting Commissions that will be released from